KEGG term | Count | %* | P value (EASE score) | Fold enrichment |
---|---|---|---|---|
Cell Cycle | 32 | 1.18 | 7.96E-04 | 1.83 |
Lysosome | 29 | 1.07 | 2.49E-03 | 1.77 |
Apoptosis | 22 | 0.81 | 7.43E-03 | 1.80 |
Prostate cancer | 22 | 0.81 | 9.73E-03 | 1.76 |
Sphingolipid metabolism | 12 | 0.44 | 1.52E-02 | 2.19 |
TGF-beta signaling pathway | 21 | 0.78 | 1.53E-02 | 1.72 |
Nucleotide excision repair | 12 | 0.44 | 3.62E-02 | 1.95 |
Pancreatic cancer | 17 | 0.63 | 3.77E-02 | 1.68 |
N-Glycan biosynthesis | 12 | 0.44 | 4.86E-02 | 1.86 |
mTOR signaling pathway | 13 | 0.48 | 5.17E-02 | 1.78 |
Aminoacyl-tRNA biosynthesis | 11 | 0.41 | 5.20E-02 | 1.91 |
Glycine serine and threonine metabolism | 9 | 0.33 | 5.85E-02 | 2.07 |
Bladder cancer | 11 | 0.41 | 6.01E-02 | 1.87 |
Pathways in cancer | 57 | 2.11 | 6.03E-02 | 1.24 |
Glutathione metabolism | 12 | 0.44 | 8.14E-02 | 1.71 |
Nitrogen metabolism | 7 | 0.26 | 9.14E-02 | 2.17 |
Non-homologous end-joining | 5 | 0.19 | 9.65E-02 | 2.74 |